These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Whole spinal transverse myelitis in neuromyelitis optica spectrum disorder. Etemadifar M; Mousavi S; Salari M; Hosseinian SA; Mansouri AR Mult Scler Relat Disord; 2024 Jul; 87():105666. PubMed ID: 38749352 [TBL] [Abstract][Full Text] [Related]
8. Short-segment transverse myelitis lesions in a cohort of Latin American patients with neuromyelitis optica spectrum disorders. Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Antunes Barreira A; Armas E; Chiganer E; de Aquino Cruz C; Di Pace JL; Hryb JP; Lavigne Moreira C; Lessa C; Molina O; Perassolo M; Soto A; Caride A Spinal Cord; 2018 Oct; 56(10):949-954. PubMed ID: 29789706 [TBL] [Abstract][Full Text] [Related]
9. Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders. Asseyer S; Kuchling J; Gaetano L; Komnenić D; Siebert N; Chien C; Scheel M; Oertel FC; Ruprecht K; Bellmann-Strobl J; Finke C; Chakravarty MM; Magon S; Wuerfel J; Paul F; Papadopoulou A; Brandt AU Mult Scler Relat Disord; 2020 Nov; 46():102579. PubMed ID: 33296976 [TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068 [TBL] [Abstract][Full Text] [Related]
11. Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Ringelstein M; Metz I; Ruprecht K; Koch A; Rappold J; Ingwersen J; Mathys C; Jarius S; Brück W; Hartung HP; Paul F; Aktas O; Mult Scler; 2014 Jun; 20(7):882-8. PubMed ID: 24192218 [TBL] [Abstract][Full Text] [Related]
12. MRI Features of Aquaporin-4 Antibody-Positive Longitudinally Extensive Transverse Myelitis: Insights into the Diagnosis of Neuromyelitis Optica Spectrum Disorders. Chee CG; Park KS; Lee JW; Ahn HW; Lee E; Kang Y; Kang HS AJNR Am J Neuroradiol; 2018 Apr; 39(4):782-787. PubMed ID: 29449281 [TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients. Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690 [TBL] [Abstract][Full Text] [Related]
14. Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status. Kong Y; Okoruwa H; Revis J; Tackley G; Leite MI; Lee M; Tracey I; Palace J J Neurol Sci; 2016 Sep; 368():84-8. PubMed ID: 27538606 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease. Murchison A; Kitley J; Leite MI; Küker W; Palace J J Neurol Sci; 2015 Aug; 355(1-2):49-53. PubMed ID: 26026944 [TBL] [Abstract][Full Text] [Related]
16. Early and extensive spinal white matter involvement in neuromyelitis optica. Hayashida S; Masaki K; Yonekawa T; Suzuki SO; Hiwatashi A; Matsushita T; Watanabe M; Yamasaki R; Suenaga T; Iwaki T; Murai H; Kira JI Brain Pathol; 2017 May; 27(3):249-265. PubMed ID: 27082714 [TBL] [Abstract][Full Text] [Related]
17. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder. Camera V; Holm-Mercer L; Ali AAH; Messina S; Horvat T; Kuker W; Leite MI; Palace J JAMA Netw Open; 2021 Dec; 4(12):e2137833. PubMed ID: 34878547 [TBL] [Abstract][Full Text] [Related]
18. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M; J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675 [TBL] [Abstract][Full Text] [Related]
19. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206 [TBL] [Abstract][Full Text] [Related]
20. Validation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of South Indian patients. Kanikannan MA; Arepareddy PK; Mathukumalli NL; Y S; Kandadai RM; Jabeen AS; T S; Borgohain R Mult Scler Relat Disord; 2019 Oct; 35():164-169. PubMed ID: 31382202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]